Christophe Garweg

Learn More
Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: results of the XPECT trial. Grammatico A, Lip GY. Improving thromboprophylaxis using atrial fibrilla-tion diagnostic capabilities in implantable cardioverter-defibrillators: The Multi-centre Italian ANGELS of AF Project. Stroke incidence is decreasing(More)
Dobutamine stress echocardiography (DSE) has the potential to stratify patients with low-gradient aortic stenosis (AS) but little is known about ventricular dyssynchrony associated with AS. We report the case of a patient who presented AS associated with left ventricular (LV) dyssynchrony. A DSE was performed, which showed no contractile reserve but an(More)
BACKGROUND Drug safety precautions recommend monitoring of the corrected QT interval. To determine which QT correction formula to use in an automated QT-monitoring algorithm in our electronic medical record, we studied rate correction performance of different QT correction formulae and their impact on risk assessment for mortality. METHODS AND RESULTS All(More)
assessment after pediatric cardiac ablation: design and implementation of the Multi-center Study. Long-term outcomes for cryoablation of pediatric patients with atrioventricular nodal reentrant tachycardia. A dual-chamber implantable cardioverter-defibrillator (Secura DR, Medtronic) was programmed to AAIR-DDDR 60–130 b.p.m.; a monitor zone for slow(More)
Why it is important to use the correct dose of the non-vitamin K oral anticoagulants A 75-year-old woman with a history of persistent non-valvular atrial fibrillation (AF) was readmit-ted to our institution due to recurrence of AF with dyspnoea (NYHA class III). Her CHA 2 DS 2-VASC score was 5/9, and she weighed 68 kg and had a normal renal function (GFR:(More)
  • 1